No abstract
AimThis study aimed to assess the endorsement of the working COS by an international sample of
CLE leaders and experts
Arianna J Zhang, Lourdes M Perez-Chada, Victoria P Werth, Joseph F Merola
Disease Category: Rheumatology
Disease Name: Cutaneous lupus erythematosus
Age Range: 18 - 120
Sex: Either
Nature of Intervention:
- Clinical experts
- Researchers
- Recommendations for outcome measures (measurement/how)
- Consensus conference
The proposed COS was presented at the recent Fifth International Conference on Cutaneous Lupus Erythematosus (ICCLE) (JFM). Subsequently, the ICCLE meeting attendees were invited to complete a six survey assessing consensus on the proposed working COS, including endorsement of the ‘core domain’, ‘full domain’ (ie, core domains, optional important domains and research agenda domains) and ‘core outcome measurement’ sets. Additionally, they were asked to vote on their preferred CLASI (Cutaneous Lupus Erythematosus Disease Area and Severity Index) primary endpoint with regard to percentage change compared with baseline (CLASI50, CLASI70 or CLASI90) and the complementary Cutaneous Lupus Activity Investigator’s Global Assessment (revised version) (CLA-IGA-R)
instrument as key secondary (vs co-primary endpoint). Appropriate patient-reported outcome measures were also considered.